Suppr超能文献

蛋白酶体:超越癌症的多种疾病有希望的治疗靶标。

Proteasome, a Promising Therapeutic Target for Multiple Diseases Beyond Cancer.

机构信息

School of Medicine, Zhejiang University City College, Hangzhou, Zhejiang Province, 310015, People's Republic of China.

Department of Pharmaceutical Preparation, Hangzhou Xixi Hospital, Hangzhou, Zhejiang Province, 310023 People's Republic of China.

出版信息

Drug Des Devel Ther. 2020 Oct 19;14:4327-4342. doi: 10.2147/DDDT.S265793. eCollection 2020.

Abstract

Proteasome is vital for intracellular protein homeostasis as it eliminates misfolded and damaged protein. Inhibition of proteasome has been validated as a powerful strategy for anti-cancer therapy, and several drugs have been approved for treatment of multiple myeloma. Recent studies indicate that proteasome has potent therapeutic effects on a variety of diseases besides cancer, including parasite infectious diseases, bacterial/fungal infections diseases, neurodegenerative diseases and autoimmune diseases. In this review, recent developments of proteasome inhibitors for various diseases and related structure activity relationships are going to be summarized.

摘要

蛋白酶体对于细胞内蛋白质的稳态至关重要,因为它可以消除错误折叠和受损的蛋白质。抑制蛋白酶体已被证实是一种有效的抗癌治疗策略,并且已经有几种药物被批准用于治疗多发性骨髓瘤。最近的研究表明,蛋白酶体除了癌症之外,对多种疾病(包括寄生虫感染性疾病、细菌/真菌感染性疾病、神经退行性疾病和自身免疫性疾病)也具有强大的治疗作用。在这篇综述中,将总结蛋白酶体抑制剂在各种疾病中的最新发展和相关的构效关系。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验